Stay updated with breaking news from Celltrion Co. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
/PRNewswire/ -- The breast cancer monoclonal antibodies market is expected to grow by USD 15 billion from 2022 to 2027. In addition, the momentum of the market...
/PRNewswire/ -- The gastric cancer drugs market size is expected to grow by USD 12.764 billion from 2022 to 2027. In addition, the momentum of the market will...
/PRNewswire/ -- The global cancer biologics market size is expected to grow by USD 34.97 billion between 2021 and 2025, expanding at a CAGR of 8.91% during the...
/PRNewswire/ -- The cancer biologics market share is expected to grow by USD 34.97 bn from 2021 to 2026, progressing at a CAGR of 8.91% during the forecast...
Global Biosimilar Monoclonal Antibodies (mAbs) Market in Pharmaceuticals Industry|Discover Company Insights in Technavio News provided by Share this article Share this article NEW YORK, July 23, 2021 /PRNewswire/ -- The biosimilar monoclonal antibodies (mAbs) market is poised to grow by USD 3.48 billion during 2021-2025, progressing at a CAGR of 14.05% during the forecast period. Here is an Exclusive report talking about Market scenarios, Estimates, the impact of lockdown, and Customer Behaviour. Attractive Opportunities in Biosimilar Monoclonal Antibodies (mAbs) Market - Forecast 2021-2025...